Company: REVB
Filing Date: 2025-04-04
Form Type: DRS
Source: 0001213900-25-029022
Chunk: 194

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-04-04
Form: DRS
Chunk 194
---
 proceeds received by the Company in the public offering, totaling $1.2 million of issuance costs. The shares of common stock underlying the Class C Pre -FundedWarrants and the shares of common stock underlying the Class C Common Stock Warrants were registered with the SEC on Form S -1(File No. 333 -268576) and was declared effective by the SEC on February 9, 2023. Between February 14, 2023 and April 6, 2023, the Company received notices of cash exercise for the Class C Pre -FundedWarrants issued in connection with the February 2023 Public Offering for 699 shares of common stock at a total purchase price of $33.64. As of December 31, 2024, there were no Class C Pre -FundedWarrants outstanding. Using a Monte -Carlosimulation model, the Class C Common Stock Warrants were valued in the aggregate at $14.0 million and included in the issuance costs of the February 2023 Public Offering and treated as a liability (see Note 10). From March 13, 2023 to December 31, 2024, the Company received notices of alternative cashless exercises for 6,217,640 Class C Common Stock Warrants issued in connection with the February 2023 Public Offering for 5,160shares of common stock. As of December 31, 2024, there were 232,360 of Class C Common Stock Warrants outstanding to purchase up to 485shares of common stock. As part of the Class D Warrant Inducement (defined below) on August 22, 2024, the exercise price of the Class C Common Stock Warrants was reset from $38.24 to $16.00. 6. 2024 Public Offering On February 5, 2024, the Company closed a public offering of 8,029shares of its common stock, 77,282 pre -fundedwarrants to purchase shares of common stock with an exercise price of $0.0016 which did not have an expiration date (the “Class D Pre -FundedWarrants”) and 2,730,000 warrants to purchase up to 170,628shares of common stock with an exercise price of $72.48 which expire on February 5, 2029 (the “Class D Common Stock Warrants”) at a combined offering price of $72.48 per share of common stock and two Class D Common